“No one wants to get surgery if they can avoid it. Now we have a powerful tool to help patients and their doctors predict who would benefit from surgery after initial chemotherapy and radiation."

The facility will provide much needed developmental and manufacturing support for pharmaceutical companies that produce and distribute medical isotopes.

Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.

It has long been believed that hormone therapy could have neuroprotective effects on the brain. However, new data suggests that this isn't the case for every woman.

The unique preferences of different readers highlight a need for more quantitative measures of quality specific to subspecialties. 

By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying these tumors by as much as 30% compared to the standard of care.

Dana Ataya, MD, is backed by Moffitt Cancer Center's band, The ReMissions.

The Obsidio Conformable Embolic is routinely used for vascular embolization procedures.

The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

The news comes just days after CMS confirmed these technologies would start receiving expanded Medicare coverage in November. HeartFlow and other AI vendors have already shared their excitement over the decision.